Dual-Code Genetic System Shows Promise in Cell-Free Protein Production

George Church's team engineered a synthetic biology system to simultaneously process two genetic codes in cell-free conditions, enabling dual protein output from a single mRNA molecule.

Researchers from George Church's team developed a system to operate two distinct genetic codes simultaneously in synthetic biology contexts. The approach involves engineering transfer RNAs (tRNAs) with specific sequence modifications to create two populations that interact with separate ribosome populations. This allows a single messenger RNA molecule to produce two different proteins in cell-free conditions, using robotics, next-generation sequencing, and analytical chemistry. The system was published in August 2026.

The mechanism enables higher throughput protein production without requiring living cells. This could reduce costs for therapeutic proteins if the system scales in controlled laboratory settings. However, the technology has not been tested in living cells and faces challenges with tRNA charging efficiency that varies by sequence modification. Maintaining dual code functionality requires precise ribosome engineering, and the system may encounter functional issues in cellular environments.

This advancement moves the need for affordable therapeutic proteins closer to reality by accelerating cell-free protein synthesis. If the system proves stable in lab-scale production, it could lower costs for specific protein therapies. But without validation in living cells, its impact on scalable medicine or crop development remains unproven. Next steps include testing the system’s stability in cellular environments and resolving tRNA charging efficiency variations. The current research is a proof-of-concept for synthetic biology workflows, not a solution for real-world applications.

Source: Ars Technica